Evaluation of the Efficacy of Aloe-Vera el Versus Bezydamine Hydrochloride in the Prevention of Radiation Induced Oral Mucositis A Randamized Controlled Clinical Trial
Launched by OCTOBER 6 UNIVERSITY · Mar 11, 2025
Trial Information
Current as of May 09, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • The study will include patients who are diagnosed with radiation-induced oral mucositis with any of its grades as scored by the world health organization (WHO) oral mucositis grading scale.
- Exclusion Criteria:
- • patients under the age of 18 ,patients receiving any previous treatment for oral mucositis during the last 2 weeks, allergy to aloe-vera, patients with chronic liver disease, infectious diseases (HIV, HBV,HCV,....), immune system dysfunction, haematological diseases and pregnancy or breast-feeding
About October 6 University
October 6 University is a prestigious educational institution dedicated to advancing medical research and clinical trials. With a strong emphasis on innovation and excellence, the university fosters a collaborative environment that integrates cutting-edge scientific research with practical clinical applications. Its commitment to improving healthcare outcomes is reflected in its comprehensive approach to clinical trials, where it engages in rigorous methodologies and ethical standards to ensure the safety and efficacy of new treatments. Through its dedicated research facilities and highly qualified personnel, October 6 University aims to contribute significantly to the global medical community and enhance patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported